iShares Nasdaq Biotechnology Index Fund Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (89)

Latest Posts

About This Stock More About This Stock
Market Shoots Arrows And Throws Daggers
Article By: Michele Schneider
Sunday, October 21, 2018 8:34 AM EDT
With lots of technical damage done in the last 2 weeks, on top of the Chinese astrological prophecy, is there any good news for the coming week?
In this article: IBB, QQQ, DIA, IWM, KRE, SMH, SPY, XRT, IYT
Read
The Stock Market Drives Into The Fog
Article By: Michele Schneider
Thursday, October 18, 2018 11:12 PM EDT
Transportation IYT , the Russell 2000, Semiconductors SMH, and Regional Banks KRE (the Economic Modern Family) all are below their 50-week moving averages. Only the S&P 500 SPY, the Dow DIA and NASDAQ QQQ are still holding their 50-WMAs.
In this article: IBB, QQQ, DIA, IWM, IYT, KRE, SMH, SPY, XRT
Read
Biotech Bull Market Under Pressure: Now Flat To Down In 2018
Article By: Rod Raynovich
Tuesday, October 16, 2018 11:15 AM EDT
Here are some positive and negative indicators to consider on the future direction of biotechnology stocks.
In this article: IBB Also: QQQ, MRK, AMGN, CELG, VRTX, IJT, IWM, XBI, XLV, ABBV, TSRO
Read
In Any Language, Market Puts Up A Cautionary Sign
Article By: Michele Schneider
Sunday, October 14, 2018 3:23 AM EDT
If ripened fruit has not been picked from a tree, it will eventually fall. Considering how overripe the market and economy have been, not surprising many traders got a nasty bump on their heads.
In this article: IWM, IYT, QQQ, DIA, IBB, KRE, SMH, XRT
Read
Can The Bulls Count On Corporate Suits?
Article By: Michele Schneider
Sunday, October 7, 2018 11:17 AM EDT
Starting with last Monday, the divergence between the Dow and the Russell 2000 became a hot topic. All throughout the week, rates and the dollar rose along with oil. The Dow made a new high, but did so all alone.
In this article: IBB, QQQ, IYM, IYT, SMH, SPY, TLT, UUP, XRT
Read

PARTNER HEADLINES

Latest Tweets for $IBB

No tweets yet!